Neuromarket
Neuromarket ‘Street drugs’, – desire and despair – have a new market.
Tag: Esketamine
‘Medicines on the horizon’
RCPsych in Scotland is the professional medical body for psychiatry in Scotland and “set standards and promote excellence in psychiatry and mental healthcare.” The next continuing medical educational event for … Continue reading ‘Medicines on the horizon’
The promotion of ESKETAMINE
Kings College London [KCL] has received over £800,000 from Janssen for Esketamine research. Professor Allan Young, Vice Dean and Clinical Academic Lead for KCL, features in this Guardian “Exclusive” [from … Continue reading The promotion of ESKETAMINE
Full page advert in the BMJ
GP edition of the BMJ. 26 September 2020.
Neuromarket
Neuromarket ‘Street drugs’, – desire and despair – have a new market.
Esketamine: Regulators and a confusing narrative
I recently shared a BMJ report that outlined the approval of Esketamine in Europe: Since sharing this news, the following rapid response by the MHRA [The Medicines and Healthcare products … Continue reading Esketamine: Regulators and a confusing narrative
“Esketamine is approved in Europe”
The BMJ has published this News report, the full article can be accessed here.
Ketamine: “lost in translation?”
Last month I shared a BMJ Editorial on Ketamine by Dr Sameer Jauhar and Dr Paul Morrison. Since then there have been a number of published BMJ responses and replies. … Continue reading Ketamine: “lost in translation?”